U.S. Markets closed

RMS Medical Products to Report Third Quarter 2018 Results October 23, 2018

CHESTER, NY / ACCESSWIRE / October 16, 2018 / Repro Med Systems, Inc. dba RMS Medical Products (REPR) today announced that it will release its financial results for the third quarter ended September 30, 2018, after the close of the financial markets on Tuesday, October 23, 2018.

An accompanying conference call will be hosted by Dan Goldberger, Chairman and interim Chief Executive Officer, Karen Fisher, Chief Financial Officer and Don Pettigrew, President and Chief Commercial Officer. The call will be held at 9:00AM ET, on Wednesday, October 24 2018. Please refer to the information below for conference call dial-in information and webcast registration.

Conference Details

Conference Date: Wednesday, October 24, 2018 9:00 AM ET
Conference Dial-In: 877.269.7756
International Dial-In: 201.689.7817
Conference Call Name: RMS Medical Products (REPR) Third Quarter 2018 Results Call
Webcast Registration: Click Here

Following the live call, a replay will be available for six months on the Company's website, www.rmsmedpro.com, under "Investor Relations."

About RMS Medical Products

The Company develops, manufactures and commercializes medical products used for home infusions and suctioning. The FREEDOM Syringe Infusion System currently includes the FREEDOM60® and FreedomEdge® Syringe Infusion Drivers, RMS Precision Flow Rate Tubing™ and RMS HIgH­Flo Subcutaneous Safety Needle Sets™. These devices are used for infusions administered in professional healthcare settings as well as at home. The Company's RES­Q­VAC® line of medical suctioning products is used by emergency medical service providers in addition to a variety of other healthcare providers. For more information about RMS Medical Products, please visit www.rmsmedicalproducts.com.

Contact

CG Capital
877.889.1972
investorrelations@cg.capital
www.cg.capital

SOURCE: Repro Med Systems, Inc.